NICE says ‘yes ‘ to bosutinib for chronic myeloid leukaemia
The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Bosulif (bosutinib) for treating some people with chronic myeloid leukaemia.
Click on this link for more information.
